We are live on ! Find out more
SONM icon

DNA X Inc
SONM

19 hedge funds and large institutions have $849K invested in DNA X Inc in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

19% more funds holding

Funds holding: 16 → 19 (+3)

0% less ownership

Funds ownership: 0.02% → 0.02% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

18% less capital invested

Capital invested by funds: $1.03M → $849K (-$181K)

Holders
19
Holders Change
+3
Holders Change %
+18.75%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$33K
2
Millennium Management
Millennium Management
New York
+$4.55K
3
UBS Group
UBS Group
Switzerland
+$3.44K
4
TRCT
Tower Research Capital (TRC)
New York
+$1.97K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$123

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$23.5K
2
TSS
Two Sigma Securities
New York
-$23.2K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$3.32K
4
BlackRock
BlackRock
New York
-$738
5
Bank of America
Bank of America
North Carolina
-$18
Name Holding Trade Value Shares
Change 		Change in
Stake
SA
1
Sicart Associates
New York
$252K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$183K +$123 +1 +0.1%
Bank of New York Mellon
3
Bank of New York Mellon
New York
$123K -$3.32K -27 -2%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$112K – – –
BlackRock
5
BlackRock
New York
$29.4K -$738 -6 -2%
Renaissance Technologies
6
Renaissance Technologies
New York
$29K -$23.5K -191 -42%
Commonwealth Equity Services
7
Commonwealth Equity Services
Massachusetts
$29K +$33K +268 New
State Street
8
State Street
Massachusetts
$26K – – –
Millennium Management
9
Millennium Management
New York
$17.6K +$4.55K +37 +30%
FFA
10
First Foundation Advisors
California
$15K – – –
Northern Trust
11
Northern Trust
Illinois
$10.5K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$10.2K +$1.97K +16 +21%
Citigroup
13
Citigroup
New York
$8.91K – – –
UBS Group
14
UBS Group
Switzerland
$3.04K +$3.44K +28 New
Wells Fargo
15
Wells Fargo
California
$101 – – –
Fidelity Investments
16
Fidelity Investments
Massachusetts
$83 +$123 +1 New
EL
17
EMFO LLC
Florida
$61 – – –
OPTFSNA
18
Old Point Trust & Financial Services N A
Virginia
$61 +$123 +1 New
JP Morgan Chase
19
JP Morgan Chase
New York
$29 – – –
TSS
20
Two Sigma Securities
New York
– -$23.2K -176 Closed
Bank of America
21
Bank of America
North Carolina
– -$18 – –

SONM Hedge Fund Activity: Q1 2024 in Review

19 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q1 2024, worth a combined $849K — down 18% from $1.03M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new SONM positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Commonwealth Equity Services, opening a new position worth an estimated $33K. The largest seller was Renaissance Technologies, cutting an estimated $23.5K.

  • 19 institutional investors held DNA X Inc (SONM) as of Q1 2024, up from 16 in Q4 2023.
  • Funds reported $849K of DNA X Inc stock for Q1 2024, down 18% quarter-over-quarter.
  • 4 funds opened new DNA X Inc positions in Q1 2024 and 1 closed out, a net change of +3 holders.
  • The largest DNA X Inc buyer in Q1 2024 was Commonwealth Equity Services, an estimated $33K added.
  • The largest DNA X Inc seller in Q1 2024 was Renaissance Technologies, an estimated $23.5K sold.

Based on aggregated 13F filings for Q1 2024.